Diabetes
Diabetes(糖尿病)
Diabetes 相关产品(254)
An anionic fluorescent dye
An internal standard for the quantification of 9-PAHSA
An antidiabetic peptide that forms amyloid fibrils
C16 Sphingomyelin (d18:1/16:0)是一种鞘磷脂形式，可变酰化位点包含palmitate (16:0)。
C18 Ceramide (d18:1/18:0)是Ceramide在细胞内经过代谢产生的一种内源性生物活性鞘脂，可通过血脑屏障，是海马区受损后产生的主要神经酰胺。
C18 dihydro Ceramide (d18:0/18:0)是一种生物活性鞘脂，也是缺乏4,5-反式双键的C18 ceramide从头合成的前体。
C18:1 Ceramide (d18:1/18:1(9Z))是一种天然鞘氨醇与油酸结合的鞘酰胺亚型。
A metabolite and degradation product of captopril
A metabolite of dapagliflozin
An incretin hormone
| 货号 | 产品名称 | CAS号 | 纯度 | 结构 |
|---|---|---|---|---|
| GC42620 | 8-Aminopyrene-1,3,6-trisulfonic Acid (sodium salt) | 196504-57-1 | >95.00% | |
An anionic fluorescent dye | ||||
| GC42655 | 9-PAHSA 13C4 | 2748638-71-1 | >95.00% | |
An internal standard for the quantification of 9-PAHSA | ||||
| GC42786 | Aminoacetone (hydrochloride) | 7737-17-9 | >98.00% | |
A catabolite of threonine and glycine | ||||
| GC42791 | Amorfrutin B | 78916-42-4 | >97.00% | |
A PPARγ agonist | ||||
| GC42795 | Amylin (human) (amidated) (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||
| GC42796 | Amylin (human) (trifluoroacetate salt) | - | >95.00% | |
An antidiabetic peptide that forms amyloid fibrils | ||||
| GC42797 | Amylin (rat, mouse) (trifluoroacetate salt) | - | >95.00% | |
A peptide hormone | ||||
| GC42805 | AN-7 | 691410-93-2 | >98.00% |  |
A potent antioxidant lipoic acid analog | ||||
| GC43022 | C14 Ceramide (d18:1/14:0) | 34227-72-0 | >95.00% / >97.00% | |
A bioactive sphingolipid | ||||
| GC43033 | C16 Lactosylceramide (d18:1/16:0) | 4201-62-1 | >98.00% | |
A bioactive sphingolipid | ||||
| GC43035 | C16 Sphingomyelin (d18:1/16:0) | 6254-89-3 | >98.00% / >99.00% | |
C16 Sphingomyelin (d18:1/16:0)是一种鞘磷脂形式，可变酰化位点包含palmitate (16:0)。 | ||||
| GC43047 | C18 Ceramide (d18:1/18:0) | 2304-81-6 | >98.00% | |
C18 Ceramide (d18:1/18:0)是Ceramide在细胞内经过代谢产生的一种内源性生物活性鞘脂，可通过血脑屏障，是海马区受损后产生的主要神经酰胺。 | ||||
| GC43048 | C18 dihydro Ceramide (d18:0/18:0) | 2304-80-5 | >98.00% / >99.00% | |
C18 dihydro Ceramide (d18:0/18:0)是一种生物活性鞘脂，也是缺乏4,5-反式双键的C18 ceramide从头合成的前体。 | ||||
| GC43055 | C18:1 Ceramide (d18:1/18:1(9Z)) | 5966-28-9 | >98.00% | |
C18:1 Ceramide (d18:1/18:1(9Z))是一种天然鞘氨醇与油酸结合的鞘酰胺亚型。 | ||||
| GC43068 | C20 Sphingomyelin (d18:1/20:0) | 121999-68-6 | >98.00% | |
A sphingolipid | ||||
| GC43075 | C24 dihydro Ceramide (d18:0/24:0) | 6063-36-1 | >98.00% | |
A sphingolipid | ||||
| GC43113 | Caerulein (acetate) | 2760881-68-1 | >95.00% | |
An oligopeptide | ||||
| GC43140 | Captopril Disulfide | 64806-05-9 | >95.00% | |
A metabolite and degradation product of captopril | ||||
| GC43180 | CAY10592 | 685139-10-0 | >98.00% |  |
A selective partial PPARδ agonist | ||||
| GC43376 | Dapagliflozin-3-O-β-D-Glucuronide | 1351438-75-9 | >95.00% | |
A metabolite of dapagliflozin | ||||
| GC43671 | FKGK 18 | 1071001-09-6 | >95.00% |  |
An inhibitor of GVIA iPLA 2 | ||||
| GC43732 | Ganglioside GM3 Mixture (sodium salt) | 54827-14-4 | >98.00% | |
A mixture of ganglioside G M3 | ||||
| GC43762 | GLP-1 (7-36) amide (trifluoroacetate salt) | - | >98.00% | |
A GLP-1R agonist | ||||
| GC43763 | GLP-1 (7-37) (human, bovine, guinea pig, mouse, rat) (trifluoroacetate salt) | - | >95.00% | |
An incretin hormone | ||||